EGRX insider filings
EAGLE PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-01. Screen EGRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for EGRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — EAGLE PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-01 | 4 | Tarriff Scott — 10% owner | Tax withholding (F): 2,119 @ $6.27 | EDGAR |
| 2024-02-29 | 4 | Cahill Brian Joseph — CHIEF FINANCIAL OFFICER | Grant/award (A): 3,800 @ $0 · Tax withholding (F): 1,589 @ $6.44 | EDGAR |
| 2024-02-29 | 4 | Tarriff Scott — 10% owner | Grant/award (A): 12,950 · Tax withholding (F): 3,154 @ $6.44 | EDGAR |
| 2024-02-06 | 4 | Cahill Brian Joseph — CHIEF FINANCIAL OFFICER | Tax withholding (F): 934 @ $5.85 | EDGAR |
| 2024-01-09 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 735 @ $5.13 | EDGAR |
| 2024-01-09 | 4 | Tarriff Scott — 10% owner | Tax withholding (F): 4,322 @ $5.13 | EDGAR |
| 2023-12-22 | 4 | Graves Michael — Interim Executive Chair & PEO, Director | Grant/award (A): 293,000 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 452 @ $4.76 | EDGAR |
| 2023-11-03 | 4 | Tarriff Scott — CEO, Director, 10% owner | Sale (S): 10,925 @ $13.82 · Sale (S): 10,694 @ $13.87 | EDGAR |
| 2023-10-31 | 4 | Graves Michael — Director | Option exercise (M): 9,360 @ $4.94 · Option exercise (M): 9,360 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | Tarriff Scott — CEO, Director, 10% owner | Sale (S): 9,511 @ $15.23 · Sale (S): 10,024 @ $14.41 · Sale (S): 710 @ $15.11 | EDGAR |
| 2023-05-18 | 4 | Tarriff Scott — CEO, Director, 10% owner | Sale (S): 15,000 @ $19.98 | EDGAR |
| 2023-05-15 | 4 | Tarriff Scott — CEO, Director, 10% owner | Sale (S): 15,000 @ $20.71 · Sale (S): 3,131 @ $19.69 · Sale (S): 11,869 @ $20.42 · Sale (S): 14,800 @ $21.06 · Sale (S): 200 @ $21.52 | EDGAR |
| 2023-03-09 | 4 | BORIO LUCIANA — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Edlin Richard A. — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Glenning Robert — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Simpson Jennifer K. — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Graves Michael — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | RATOFF STEVEN B — Director | Grant/award (A): 16,253 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 718 @ $28 · Grant/award (A): 18,500 @ $0 | EDGAR |
| 2023-03-02 | 4 | Tarriff Scott — CEO, Director, 10% owner | Tax withholding (F): 3,113 @ $28 · Grant/award (A): 70,900 @ $0 | EDGAR |
| 2023-02-06 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 785 @ $34.09 | EDGAR |
| 2023-01-31 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 601 @ $33.21 | EDGAR |
| 2023-01-24 | 4 | Tarriff Scott — CEO, Director, 10% owner | Tax withholding (F): 3,732 @ $33.64 | EDGAR |
| 2023-01-09 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 734 @ $29.26 | EDGAR |
| 2023-01-09 | 4 | Tarriff Scott — CEO, Director, 10% owner | Tax withholding (F): 3,827 @ $29.26 | EDGAR |
| 2022-12-21 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 461 @ $30.03 | EDGAR |
| 2022-09-08 | 4 | Edlin Richard A. — Director | Sale (S): 6,800 @ $30.99 | EDGAR |
| 2022-03-02 | 4 | Moran Michael Shawn — EVP, Chief Commercial Officer | Grant/award (A): 10,400 @ $0 | EDGAR |
| 2022-03-02 | 4 | BORIO LUCIANA — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Cahill Brian Joseph — Chief Financial Officer | Grant/award (A): 8,000 @ $0 | EDGAR |
| 2022-03-02 | 4 | Edlin Richard A. — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Glenning Robert — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Simpson Jennifer K. — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Tarriff Scott — CEO, Director, 10% owner | Grant/award (A): 34,800 @ $0 | EDGAR |
| 2022-03-02 | 4 | Graves Michael — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | RATOFF STEVEN B — Director | Grant/award (A): 11,200 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | Moran Michael Shawn — EVP, Chief Commercial Officer | Tax withholding (F): 742 @ $45.03 | EDGAR |
| 2022-02-04 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 805 @ $45.03 | EDGAR |
| 2022-02-01 | 4 | Moran Michael Shawn — EVP, Chief Commercial Officer | Tax withholding (F): 210 @ $45.94 | EDGAR |
| 2022-02-01 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 626 @ $45.94 | EDGAR |
| 2022-01-11 | 4 | Moran Michael Shawn — EVP, Chief Commercial Officer | Tax withholding (F): 90 @ $50.63 | EDGAR |
| 2022-01-11 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 263 @ $50.63 | EDGAR |
| 2022-01-07 | 4 | Moran Michael Shawn — EVP, Chief Commercial Officer | Tax withholding (F): 1,511 @ $50.69 | EDGAR |
| 2022-01-07 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 738 @ $50.69 | EDGAR |
| 2021-12-21 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 467 @ $55.42 | EDGAR |
| 2021-04-30 | 4 | BORIO LUCIANA — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2021-04-12 | 4 | RATOFF STEVEN B — Director | Option exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 @ $4.42 · Option exercise (M): 2,340 (derivative) @ $0 · Option exercise (M): 2,340 (derivative) @ $0 · Option exercise (M): 2,340 (derivative) @ $0 | EDGAR |
| 2021-04-07 | 4 | RATOFF STEVEN B — Director | Option exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | Tarriff Scott — CEO, Director, 10% owner | Gift (G): 16,340 @ $0 · Option exercise (M): 31,201 @ $8.78 · Tax withholding (F): 16,278 @ $41.87 · Option exercise (M): 31,201 (derivative) @ $0 | EDGAR |
Recent 8-K events — EAGLE PHARMACEUTICALS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-12-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-27 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-02 | 8-K | 2.02 — Results of Operations and Financial Condition 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 8.01 — Other Events | EDGAR |
| 2024-08-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-07-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2024-05-29 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EGRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs